Cybin bags breakthrough tag for psychedelic depression drug
pharmaphorum
MARCH 14, 2024
Cybin files a $150m placement on the back of new clinical data with its psychedelic drug CYB003 for depression and an FDA breakthrough designation.
tag psychedelics 
113 
Walking Each Other Home with Community-Based Psychedelic Support
The Spirit Pharmacist
DECEMBER 2, 2021
Psychedelic therapies are making headlines due to the unprecedented benefits demonstrated in clinical trials for persons with refractory mental illnesses. However, psychedelic assisted therapy is resource intensive and will likely come with a price tag putting it out of reach of many persons that could benefit from such therapies.
Let's personalize your content